• SENSEX 82,188.99
    746.95 (+0.92%)
  • BANKNIFTY 56,578.40
    817.55 (+1.47%)
  • Cochin Shipyard
    2,547.25 2,977.10(%)
  • Azad Engineering
    1,561.00 1,128.40(%)
  • Garden Reach Sh.
    3,199.05 1,180.10(%)
  • HDFC Bank
    1,996.30 1,996.30(%)
  • Reliance Industr
    1,451.35 1,608.95(%)
  • Reliance Power
    63.13 63.39(%)
  • Natl. Aluminium
    190.90 263.10(%)
  • HFCL
    92.19 171.00(%)
  • Ramkrishna Forg.
    674.40 1,064.00(%)
  • Suzlon Energy
    66.10 46.00(%)
  • IDFC First Bank
    72.25 84.50(%)
  • Sika Interplant
    1,265.00 399.96(%)
  • Multi Comm. Exc.
    7,529.95 7,529.95(%)
  • St Bk of India
    816.45 898.80(%)
  • Mazagon Dock
    3,380.30 1,417.20(%)
  • Hindustan Zinc
    510.75 717.10(%)
  • ICICI Bank
    1,461.95 1,471.10(%)
  • REC Ltd
    417.30 653.90(%)
  • Eternal Ltd
    264.10 304.50(%)
  • Bharat Electron
    389.05 240.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Smruthi Organics Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 5758.0
  • ISIN : INE172E01011
127.70 -1 (-1.01%)
  • As on 07 Jun 2025 (EOD)

  • Today’s Low

    127.30

  • Today’s High

    131.80

  • Open

    131.80

  • Perv Close

    129.00

  • 52W Low

    103.00

  • 52W High

    182.45

Key Indicators

  • P/E(TTM)

    41.06

  • Mar.Cap (₹Cr.)

    146.17

  • Div & Yield %

    1.18

  • Book Value(₹)

    62.58

  • Debt-Equity Ratio

    -1.01

  • AGM Date

    06-Jun-2025

  • EPS

    3.11

  • P/E Ratio

    41.06

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    146.17

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    11.45

  • BV (₹)

    62.60

  • Sales( ₹ in Cr.)

    126.01

  • NP (in Cr.)

    3.56

  • NP Var(%)

    -1.0

  • Div%

    15.0

  • CPS (₹)

    7.90

  • EPS (₹)

    3.10

  • Traded Value (₹ in Lakhs)

    146.17

  • 52 Week High

    182.45

  • 52 Week Low

    103.00

  • Price BSE

    128.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    146.17

  • P/C Ratio

    16.20

  • P/E Ratio

    41.10

  • Price Vs.BV

    3.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 126.01 127.64 141.04 133.37 126.50 131.07
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 126.01 127.64 141.04 133.37 126.50 131.07
Other Income 0.09 0.08 0.11 0.58 0.56 4.42
Stock Adjustments -0.61 2.66 4.42 2.08 -2.78 -5.39
Total Income 125.49 130.38 145.57 136.03 124.28 130.10
EXPENDITURE :            
Raw Materials 68.00 75.01 95.89 82.14 63.68 78.09
Power and Fuel Cost 11.55 10.03 9.43 8.80 8.86 10.63
Employee Cost 17.35 17.16 15.82 13.73 15.64 13.57
Other Manufacturing Expenses 2.37 2.55 2.27 2.10 1.87 1.84
Selling and Administration Expenses 6.28 5.99 4.65 3.62 2.86 3.29
Miscellaneous Expenses 7.67 7.60 7.60 6.63 2.27 3.02
Employee Benefit Expenses 17.35 17.16 15.82 13.73 15.64 13.57
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 113.22 118.34 135.67 117.02 95.19 110.44
Operating Profit 12.27 12.03 9.89 19.01 29.09 19.66
Interest 1.87 1.41 0.82 0.98 1.09 3.18
Gross Profit 10.40 10.62 9.07 18.03 28.00 16.48
Depreciation 5.50 5.65 4.57 4.26 3.95 4.39
Profit Before Tax 4.90 4.97 4.50 13.77 24.05 12.09
Current Tax 1.37 1.61 1.46 3.56 6.81 2.98
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.03 -0.23 -1.10 -0.17 0.14 0.67
Reported Net Profit 3.56 3.59 4.13 10.38 17.11 8.45
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 3.56 3.59 4.13 10.38 17.11 8.45
Adjustment below Net Profit 0.00 0.00 0.30 -0.28 0.92 -0.06
P & L Balance brought forward 56.48 55.18 54.48 47.81 33.21 27.13
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.72 2.29 3.43 3.43 3.43 2.30
P & L Balance carried down 58.32 56.48 55.48 54.48 47.81 33.21
Dividend 0.00 0.00 0.00 0.00 0.00 2.30
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 15.00 15.00 20.00 30.00 30.00 30.00
Dividend Per Share(Rs) 1.50 1.50 2.00 3.00 3.00 3.00
Earnings Per Share-Unit Curr 3.11 3.14 3.61 9.07 14.95 22.14
Earnings Per Share(Adj)-Unit Curr 3.11 3.14 3.61 9.07 14.95 7.38
Book Value 62.58 60.82 59.54 58.68 52.85 111.29
Book Value(Adj)-Unit Curr 62.58 60.82 59.54 58.68 52.85 37.10

Shareholding Pattern

  • Promoter Group

    64.73%

  • Public Share Holding

    35.27%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 7,408,902 64.73 7,408,902 6
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,408,902 64.73 7,408,902 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 398,028 3.48 161,928 28
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 137,441 1.20 65,441 113
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 88,172 0.77 88,172 123
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 615,379 5.38 615,379 16
Individuals holding nominal share capital up to Rs. 1 lakh 2,684,611 23.45 2,468,211 5,618
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 113,757 0.99 113,757 1
Sub Total 4,037,388 35.27 3,512,888 5,899
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 11,446,290 100.00 10,921,790 5,905

Company Background

Smruthi Organics LtdPharmaceuticals - Indian - Bulk Drugs

  • Smruthi Organics Ltd
  • BSE Code : 5758.0
  • ISIN : INE172E01011

  • Incorporation Year

    1989

  • Registered Office

    165-A Balaji Bhavan 1st Floor
    Railway Lines, Solapur,
    Maharashtra-413001

  • Telephone

    91-217-2310267/2310268

  • FAX

    91-217-2310268

  • Chairman

    E Purushotham

  • Managing Director

    E Purushotham

  • Company Secretary

    Urvashi D Khanna

  • Auditor

    Gokhale & Sathe

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Adroit Corp. Services Pvt Ltd
    19/20 Jaferbhoy Ind,
    1st Floor Makwana Rd,Marol Naka
    Mumbai - Mumbai - 400 059

Smruthi Organics Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Smruthi Organic 127.70 126.10 126.01 41.06 7.97
Abbott India 31,751.10 6,097.18 5,848.91 47.70 44.71
Astrazeneca Phar 9,791.90 1,330.33 1,295.53 211.49 33.26
P & G Health Ltd 5,550.45 1,166.89 1,151.26 36.68 39.76
Glaxosmi. Pharma 3,431.50 3,866.05 3,723.49 63.25 58.72
Cipla 1,503.75 17,645.00 16,574.34 23.55 20.10
Amrutanjan Healt 714.85 437.58 421.23 40.66 20.84
Guj. Themis Bio. 322.55 174.19 169.82 72.00 44.82
Fermenta Biotec. 321.90 315.24 307.09 14.01 4.10
Bliss GVS Pharma 136.50 638.96 605.46 20.84 11.19
Ambalal Sarabhai 35.88 11.70 3.81 33.22 1.92